Rotigotine vs ropinirole in advanced stage Parkinson's disease: AÂ double-blind study

Rotigotine was well tolerated at doses up to 16 mg/24 h and showed similar efficacy to ropinirole except that the application site reaction was much higher in the rotigotine group.